4.6 Review Book Chapter

The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases

期刊

ANNUAL REVIEW OF IMMUNOLOGY, VOL 29
卷 29, 期 -, 页码 707-735

出版社

ANNUAL REVIEWS
DOI: 10.1146/annurev-immunol-031210-101405

关键词

innate immunity; metabolic diseases; cancer; IL-1 beta; caspase-1

资金

  1. NCI NIH HHS [R21CA131645, R21 CA131645] Funding Source: Medline
  2. NIAID NIH HHS [R01 AI063031, U54 AI057157, R01-AI063031, U54-AI057157] Funding Source: Medline
  3. NIDCR NIH HHS [R01-DE018281, R01-DE016326, R01 DE016326, R01 DE018281] Funding Source: Medline
  4. NATIONAL CANCER INSTITUTE [R21CA131645] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157, R01AI063031] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Inflammasome activation leads to caspase-1 activation, which causes the maturation and secretion of pro-IL-1 beta and pro-IL-18 among other substrates. A subgroup of the NLR (nucleotide-binding domain, leucine-rich repeat containing) proteins are key mediators of the inflammasome. Studies of gene-deficient mice and cells have implicated NLR inflammasomes in a host of responses to a wide range of microbial pathogens, inflammatory diseases, cancer, and metabolic and autoinumine disorders. Determining exactly how the inflammasome is activated in these diseases and disease models remains a challenge. This review presents and integrates recent progress in the field.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据